Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Skeletal muscle
77%
Fibrosis
67%
Sarcopenia
64%
Skeletal muscle Atrophy
52%
Muscle Strength
52%
Nonalcoholic Steatohepatitis
49%
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
48%
Duchenne muscular Dystrophy
43%
Angiotensin 1-7
43%
Transforming Growth Factor Type β
42%
CCN2
42%
Chronic Liver Disease
41%
Oxidative Stress
37%
Mdx Mice
36%
Liver
35%
Bile Acids
33%
Connective Tissue Growth Factor
29%
Muscular Dystrophy
28%
Dystrophic muscle
28%
Transforming Growth Factor-β
27%
Dystrophic
26%
Steatotic Liver Disease
26%
High-fat Diet
25%
Skeletal muscle Cells
24%
Myosin Heavy Chain (MyHC)
24%
Profibrotic
23%
Hepatocytes
23%
Andrographolide
23%
Mouse Model
22%
Inflammation
22%
Liver Disease
21%
TGR5
21%
Protein Level
21%
Muscle Fiber
21%
Muscle Mass
20%
Muscle Wasting
20%
Liver Disease Progression
20%
Steatosis
19%
Hepatic Steatosis
19%
Mineralocorticoid Receptor
18%
Diet-induced
17%
Myonuclear Apoptosis
17%
Ubiquitin-proteasome System
17%
Fibroblasts
17%
Decorin
17%
Muscle Atrophy
16%
Mas Receptor
16%
Hepatic Stellate Cells
16%
Fatty Acid Composition
16%
Medicine and Dentistry
Skeletal Muscle
77%
Nonalcoholic Fatty Liver
56%
Liver Disease
52%
Fibrosis
48%
angiotensin[1-7]
37%
Sarcopenia
32%
Muscle Strength
32%
Chronic Liver Disease
31%
Duchenne Muscular Dystrophy
30%
Transforming Growth Factor Beta
29%
Metabolic Dysfunction-Associated Steatotic Liver Disease
28%
Diseases
24%
Fatty Liver
24%
Bile Acid
24%
Muscle Atrophy
23%
Inflammation
21%
Receptor
21%
High Fat Food
20%
Muscular Dystrophy
19%
Liver Cirrhosis
18%
Non-Alcoholic Fatty Liver Disease
17%
Oxidative Stress
17%
Connective Tissue Growth Factor
17%
Muscle Function
16%
Cell Therapy
16%
Fatty Acid
15%
Mineralocorticoid Receptor
15%
NMR Spectroscopy
15%
Andrographolide
15%
Renin Angiotensin Aldosterone System
14%
Hepatocellular Carcinoma
14%
Biological Marker
13%
Somatomedin C
12%
Heavy Meromyosin
11%
Proteasome
11%
Ubiquitin
11%
Skeletal Muscle Atrophy
11%
Prevalence
10%
Diabetes
10%
Cholestasis
10%
Malignant Neoplasm
9%
Side Effect
9%
Myofibrosis
9%
Fibroblast
9%
Programmed Cell Death
8%
Cancer Growth Factor
8%
Triacylglycerol
8%
Innate Immunity
7%
Cytotoxic T-Cell
7%
Primary Health Care
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
63%
Muscle Atrophy
56%
Transforming Growth Factor Beta
48%
Fibrosis
44%
Inflammation
38%
Sarcopenia
34%
angiotensin[1-7]
32%
Connective Tissue Growth Factor
31%
Receptor
27%
Liver Disease
25%
Chronic Liver Disease
23%
Fatty Acid
19%
Muscular Dystrophy
19%
Fatty Liver
19%
Reactive Oxygen Metabolite
18%
Myosin Heavy Chain
18%
Diseases
18%
Bile Acid
16%
Mouse Model
16%
Experimental Steatohepatitis
16%
Duchenne Muscular Dystrophy
15%
TGF-Beta
15%
Hypoxia
15%
Mineralocorticoid Receptor
15%
Steatosis
13%
Liver Cell Carcinoma
13%
Angiotensin
13%
Inflammasome
12%
Renin
12%
Triacylglycerol
12%
Proteasome
11%
Ubiquitin
11%
Malignant Neoplasm
10%
Muscle Disease
10%
Diet Induced Obesity
10%
N-Acetylcysteine
10%
Cholestasis
9%
Sodium
8%
Cancer Growth Factor
8%
Biological Marker
8%
Disease Course
8%
Side Effect
8%
Messenger RNA
7%
Liver Fibrosis
7%
Andrographolide
7%
Growth Hormone
7%
Membrane Receptor
7%
Metabolic Disorder
7%
Sarcopenic Obesity
7%
Dexmedetomidine
7%